Discontinued — last reported Q3 '23
Lam Research Interest Paid remained flat by 0.0% to $43.09M in Q2 2025 compared to the prior quarter. Year-over-year, this metric declined by 0.4%, from $43.27M to $43.09M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows a downward trend with a -4.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
cf_interest_paid| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $203.93M | $175.53M | $174.75M | $173.09M | $172.36M |
| YoY Change | — | -13.9% | -0.4% | -0.9% | -0.4% |
We use cookies for analytics. See our Privacy and Cookie Policy.